Quick Answer
Catheter Precision, Inc. reported Total Assets of $15.86 million for the year ending 2025.
- Catheter Precision, Inc. showed a decrease of -42.9% in Total Assets from 2024 to 2025.
- This data is from Catheter Precision, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: $14.19 million | Q1 2019: $69.28 million | Q2 2019: $62.47 million | Q3 2019: $54.00 million | Q1 2020: $36.30 million | Q2 2020: $40.69 million | Q3 2020: $43.45 million | Q1 2021: $25.26 million | Q2 2021: $29.16 million | Q3 2021: $27.08 million | Q1 2022: $23.75 million | Q2 2022: $14.37 million | Q3 2022: $17.47 million | Q1 2023: $48.51 million | Q2 2023: $35.54 million | Q3 2023: $32.87 million | Q1 2024: $28.02 million | Q2 2024: $26.26 million | Q3 2024: $26.75 million | Q1 2025: $24.80 million | Q2 2025: $25.56 million | Q3 2025: $25.47 million.
- Over the full 9 years of available data (2017 to 2025), Catheter Precision, Inc.'s Total Assets has grown by 40.7%.
- Historical annual values: Fiscal year 2025: $15.86 million | Fiscal year 2024: $27.77 million | Fiscal year 2023: $30.74 million | Fiscal year 2022: $16.84 million | Fiscal year 2021: $21.04 million | Fiscal year 2020: $33.44 million | Fiscal year 2019: $44.08 million | Fiscal year 2018: $74.04 million | Fiscal year 2017: $11.27 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: